Where does Smiths Medical International Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Smiths Medical International Limited ranks #18,130 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Smiths Medical International Limited hold?

Smiths Medical International Limited holds 16 US utility patents granted between 2017 and 2024, spanning 4 technology areas.

What is Smiths Medical International Limited's Innovation Score?

Smiths Medical International Limited has an Innovation Score of 24.6 out of 100 (15th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Smiths Medical International Limited's patent grant rate increasing or decreasing?

Smiths Medical International Limited's recent grant velocity is +333% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Smiths Medical International Limited's patents?

Smiths Medical International Limited's patents average 8.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Smiths Medical International Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Smiths Medical International Limited

Q: What technology areas does Smiths Medical International Limited focus on?

Smiths Medical International Limited's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 15 patents, ranking #479 of 3,490 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 16 granted patents across 4 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Smiths ranks #18,130 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 4 technology areas.

#18,130
of 49,997 US assignees by volume: 15th percentile
by Innovation Score (24.6/100): 8.4
avg claims per patent: +333%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18130 · Foreign Corporation #18,130 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 16 grants
MID-PACK #18,130/49,997
PHOTO-FINISH Sierra Space
CPC-NARROW A61M · 4 areas
INNOV-THIN 24.6/100
CLAIMS-PAR 8.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +333% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sierra Space Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Smiths’s 24.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (40%) Velocity 2.7 pts (11%) Breadth 7.1 pts (29%) Claim depth 5.0 pts (20%)

Qualcomm Incorporated · highest

85
Smiths Medical… · this assignee

25
3D Lighting… · lowest

7

What this shows Smiths's Innovation Score is 24.6/100 (15th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Smiths?

Each dot is one of Smiths’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Smiths’s own 8.4 claims/patent is at or below the 17.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Smiths vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Smiths's grants concentrate

Smiths Medical International Limited is a focused PatentsView assignee: 4 CPC subclasses with 93.8% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2020 (5 grants) versus a trough of 1 in 2017. By volume, Smiths sits between Sierra Space Corporation and Spark Thermionics, Inc..

Smiths's three-year grant acceleration

Smiths Medical International Limited shows 4 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Sierra Space

16
Smart Wave

16
Smiledirectclub

16
Smith Micro Softw…

16
Socure

16
Soluble Group

16
Soundmed

16
Spark Thermionics

16
Smiths Medical In… ◀

16

What this shows Smiths holds 16 patents at rank #18,143, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Smiths

By rank, the assignees closest to #18,143 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Smiths's primary technology class.

Smiths's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 15th percentile higher than 15% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Smiths Medical International Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	6.3%
2018	1	6.3%
2019	1	6.3%
2020	5	31.3%
2021	4	25.0%
2022	2	12.5%
2024	2	12.5%

Which technologies does Smiths Medical International Limited patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 15

A61B - DIAGNOSIS; SURGERY; Identification 3

A63B - Apparatus FOR Physical Training, Gymnastics, Swimming, Climbing, OR FENCING; Ball GAMES; Training Equipment 3

F28D - Heat-exchange Apparatus, NOT Provided FOR IN Another Subclass, IN Which THE Heat-exchange Media DO NOT Come Into Direct Contact 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Smiths Medical International Limited's patent record in context - here's where to go next.

Smiths Medical International Limited's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 93.8% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #18,130 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Smiths Medical International Limited against Sierra Space Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 24.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.